In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

The research team found that fibrillar collagen I , a form of collagen that becomes more abundant in diabetic pancreatic tissue, creates a sticky surface that attracts amylin. Instead of floating ...